ALERT ALERT: A Public Session meeting of the New Jersey State Board of Medical Examiners is scheduled virtually for November 13, 2024. The meeting is scheduled to be called to Order at 9:00A.M. Formal action may be taken at the meeting. A copy of the Agenda can be accessed at View Agenda
For the public to participate in the meeting, from your computer, tablet or smartphone -
Join ZoomGov Meeting
Meeting ID: 160 210 7399
Passcode: 205549
One tap mobile
+16692545252,,1602107399#,,,,*205549# US (San Jose)
+16469641167,,1602107399#,,,,*205549# US (US Spanish Line)
Dial by your location
• +1 669 254 5252 US (San Jose)
• +1 646 964 1167 US (US Spanish Line)
• +1 646 828 7666 US (New York)
• +1 551 285 1373 US (New Jersey)
• +1 669 216 1590 US (San Jose)
• +1 415 449 4000 US (US Spanish Line)
• 833 568 8864 US Toll-free
• 833 435 1820 US Toll-free
Meeting ID: 160 210 7399
Passcode: 205549
Find your local number: https://njoag.zoomgov.com/u/acR9cgXWjz
Public comments will only be accepted in writing. Any public comments should be submitted by 5:00 PM on Tuesday, November 13, 2024 by emailing the Executive Director, Antonia Winstead, at bmedirector@dca.njoag.gov. The email should contain the name of the person submitting the comments and in the subject line reference “Board Meeting.” The Board will make its best efforts to read any comment received into the record during the meeting.
|
ALERT The Division of Consumer Affairs issued an alert to support health care practitioners in their efforts to protect patient data and information from disclosure. This alert, available
here, identifies steps that practitioners can take to avoid collecting unnecessary data and to safeguard the data that they do collect and store. |
ATTENTION The U.S. Department of Health and Human Services (HHS) recently announced Practice Guidelines which authorized physicians to utilize an exemption from certain certification requirements under the Controlled Substances Act to prescribe buprenorphine for the treatment of opioid use disorder. The
Practice Guidelines were sent to the Office of the Federal Register (OFR) on January 12, 2021, but were not yet published. It has been reported that the Biden Administration has delayed the implementation of the Practice Guidelines setting forth that exemption, as a
regulatory freeze has been implemented with respect to rules that have been sent to the OFR but not published, requiring that they be withdrawn for review [and approval]. This means that physicians who wish to prescribe buprenorphine for opioid use disorder must continue to adhere to the full DATA 2000 waiver requirements. HHS is expected to announce this reversal.
|
New Jersey's Board of Medical Examiners is responsible for protecting the public's health and safety by determining qualifications of applicants for licensure, establishing standards for practice, and disciplining licensees who do not adhere to those requirements. In addition to physicians and podiatrists, the Board licenses and certifies certain other health care professionals.
On this site you will find important information for consumers, licensees, applicants, hospitals, managed care entities and other institutions. You can learn more about the Medical Board and its activities, read summaries of Board actions, search for licensees by name or profession, get answers to frequently asked questions and more.
- Consumers can search for a physician or learn more about their current doctor by clicking onto the New Jersey Health Care Profile link. They may file a complaint, if necessary, about a physician or podiatrist or contact a member of the Medical Board's staff to check on the status of a complaint filed previously.
- Doctors and those in the process of becoming doctors can access online applications and renewal forms and learn more about our programs, their responsibilities, and the related activities of other agencies and organizations.
- Hospitals, managed care entities and other institutions can find access to verification services.
To keep the public informed of the Board's activities, this site will be updated regularly and will post agendas, minutes, rule proposals, and licensee status.
Our goal is to ensure that the public and our licensees have access to services and information vital to the continued delivery of health care in New Jersey. We encourage you to use the site often, and we welcome your feedback.
